Bassan Abraham reported RANI

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001864485-26-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

May 28, 2026

Published

Jun 1, 2026

Ingested by INSIDER

Nov 5, 03:55 UTC

Last re-read

Nov 5, 03:55 UTC

Extracted facts

Filer

Bassan Abraham

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Rani Therapeutics Holdings, Inc. — Director Stock Option (Right to Buy)

Ticker

RANI

Shares

123.6K

Price per share

$0

Execution date (reported)

May 28, 2026

Owned after transaction

123.6K shares

Days from execution to publication

4

What this establishes

Bassan Abraham filed this Form 4 reporting a grant or award of RANI on May 28, 2026. It became public on Jun 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Bassan Abrahamcik:0001864485

Issuer

Rani Therapeutics Holdings, Inc.cik:0001856725

Revision history · 0

No field has changed since this record was first ingested.